TY - JOUR AU - Ilett, E. E. PY - 2015 DA - 2015// TI - Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review JO - Diagnostics (Basel, Switzerland) VL - 5 ID - Ilett2015 ER - TY - JOUR AU - Fraenkel, M. AU - Kim, M. AU - Faggiano, A. AU - Herder, W. W. AU - Valk, G. D. PY - 2014 DA - 2014// TI - Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature JO - Endocr Relat Cancer VL - 21 UR - https://doi.org/10.1530/ERC-13-0125 DO - 10.1530/ERC-13-0125 ID - Fraenkel2014 ER - TY - JOUR AU - Yao, J. C. PY - 2008 DA - 2008// TI - One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.4377 DO - 10.1200/JCO.2007.15.4377 ID - Yao2008 ER - TY - JOUR AU - Anlauf, M. PY - 2011 DA - 2011// TI - Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification JO - Horm Metab Res VL - 43 UR - https://doi.org/10.1055/s-0031-1291307 DO - 10.1055/s-0031-1291307 ID - Anlauf2011 ER - TY - JOUR AU - Pavel, M. PY - 2016 DA - 2016// TI - ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site JO - Neuroendocrinology VL - 103 UR - https://doi.org/10.1159/000443167 DO - 10.1159/000443167 ID - Pavel2016 ER - TY - JOUR AU - Auernhammer, C. J. AU - Goke, B. PY - 2011 DA - 2011// TI - Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin JO - Gut VL - 60 UR - https://doi.org/10.1136/gut.2009.204453 DO - 10.1136/gut.2009.204453 ID - Auernhammer2011 ER - TY - JOUR AU - Partelli, S. t. e. f. a. n. o. AU - Bartsch, D. e. t. l. e. f. K. AU - Capdevila, J. a. u. m. e. AU - Chen, J. i. e. AU - Knigge, U. l. r. i. c. h. AU - Niederle, B. r. u. n. o. AU - Nieveen van Dijkum, E. l. s. J. M. AU - Pape, U. l. r. i. c. h. -. F. r. a. n. k. AU - Pascher, A. n. d. r. e. a. s. AU - Ramage, J. o. h. n. AU - Reed, N. i. c. k. AU - Ruszniewski, P. h. i. l. i. p. p. e. AU - Scoazec, J. e. a. n. -. Y. v. e. s. AU - Toumpanakis, C. h. r. i. s. t. o. s. AU - Kianmanesh, R. e. z. a. AU - Falconi, M. a. s. s. i. m. o. PY - 2017 DA - 2017// TI - ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours JO - Neuroendocrinology VL - 105 UR - https://doi.org/10.1159/000464292 DO - 10.1159/000464292 ID - Partelli2017 ER - TY - JOUR AU - Pavel, M. a. r. i. a. n. n. e. AU - Valle, J. u. a. n. W. AU - Eriksson, B. a. r. b. r. o. AU - Rinke, A. n. j. a. AU - Caplin, M. a. r. t. y. n. AU - Chen, J. i. e. AU - Costa, F. r. e. d. e. r. i. c. o. AU - Falkerby, J. e. n. n. y. AU - Fazio, N. i. c. o. l. a. AU - Gorbounova, V. e. r. a. AU - de Herder, W. o. u. t. e. r. AU - Kulke, M. a. t. t. h. e. w. AU - Lombard-Bohas, C. a. t. h. e. r. i. n. e. AU - O'Connor, J. u. a. n. AU - Sorbye, H. a. l. f. d. a. n. AU - Garcia-Carbonero, R. o. c. i. o. PY - 2017 DA - 2017// TI - ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents JO - Neuroendocrinology VL - 105 UR - https://doi.org/10.1159/000471880 DO - 10.1159/000471880 ID - Pavel2017 ER - TY - JOUR AU - Garcia-Carbonero, R. o. c. i. o. AU - Rinke, A. n. j. a. AU - Valle, J. u. a. n. W. AU - Fazio, N. i. c. o. l. a. AU - Caplin, M. a. r. t. y. n. AU - Gorbounova, V. e. r. a. AU - O'Connor, J. u. a. n. AU - Eriksson, B. a. r. b. r. o. AU - Sorbye, H. a. l. f. d. a. n. AU - Kulke, M. a. t. t. h. e. w. AU - Chen, J. i. e. AU - Falkerby, J. e. n. n. y. AU - Costa, F. r. e. d. e. r. i. c. o. AU - de Herder, W. o. u. t. e. r. AU - Lombard-Bohas, C. a. t. h. e. r. i. n. e. AU - Pavel, M. a. r. i. a. n. n. e. PY - 2017 DA - 2017// TI - ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy JO - Neuroendocrinology VL - 105 UR - https://doi.org/10.1159/000473892 DO - 10.1159/000473892 ID - Garcia-Carbonero2017 ER - TY - JOUR AU - Hicks, R. o. d. n. e. y. J. AU - Kwekkeboom, D. i. k. J. AU - Krenning, E. r. i. c. AU - Bodei, L. i. s. a. AU - Grozinsky-Glasberg, S. i. m. o. n. a. AU - Arnold, R. u. d. o. l. f. AU - Borbath, I. v. a. n. AU - Cwikla, J. a. r. o. s. l. a. w. AU - Toumpanakis, C. h. r. i. s. t. o. s. AU - Kaltsas, G. r. e. g. AU - Davies, P. h. i. l. i. p. p. a. AU - Hörsch, D. i. e. t. e. r. AU - Tiensuu Janson, E. v. a. AU - Ramage, J. o. h. n. PY - 2017 DA - 2017// TI - ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues JO - Neuroendocrinology VL - 105 UR - https://doi.org/10.1159/000475526 DO - 10.1159/000475526 ID - Hicks2017 ER - TY - JOUR AU - Armbruster, M. PY - 2014 DA - 2014// TI - Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography JO - Investig Radiol VL - 49 UR - https://doi.org/10.1097/RLI.0b013e3182a4eb4a DO - 10.1097/RLI.0b013e3182a4eb4a ID - Armbruster2014 ER - TY - JOUR AU - Moryoussef, F. PY - 2017 DA - 2017// TI - Impact of liver and whole-body diffusion-weighted MRI for neuroendocrine tumors on patient management: a pilot study JO - Neuroendocrinology VL - 104 UR - https://doi.org/10.1159/000446369 DO - 10.1159/000446369 ID - Moryoussef2017 ER - TY - JOUR AU - d'Assignies, G. PY - 2013 DA - 2013// TI - High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging JO - Radiology VL - 268 UR - https://doi.org/10.1148/radiol.13121628 DO - 10.1148/radiol.13121628 ID - d'Assignies2013 ER - TY - JOUR AU - Rufini, V. PY - 2012 DA - 2012// TI - Role of PET/CT in the functional imaging of endocrine pancreatic tumors JO - Abdom Imaging VL - 37 UR - https://doi.org/10.1007/s00261-012-9871-9 DO - 10.1007/s00261-012-9871-9 ID - Rufini2012 ER - TY - JOUR AU - Fiebrich, H. B. AU - Jong, J. R. AU - Kema, I. P. PY - 2011 DA - 2011// TI - Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1862-5 DO - 10.1007/s00259-011-1862-5 ID - Fiebrich2011 ER - TY - JOUR AU - Imperiale, A. PY - 2014 DA - 2014// TI - 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.126896 DO - 10.2967/jnumed.113.126896 ID - Imperiale2014 ER - TY - JOUR AU - Koopmans, K. P. PY - 2006 DA - 2006// TI - Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study JO - Lancet Oncol VL - 7 UR - https://doi.org/10.1016/S1470-2045(06)70801-4 DO - 10.1016/S1470-2045(06)70801-4 ID - Koopmans2006 ER - TY - JOUR AU - Koopmans, K. P. PY - 2008 DA - 2008// TI - Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.1126 DO - 10.1200/JCO.2007.15.1126 ID - Koopmans2008 ER - TY - JOUR AU - Schreiter, N. F. PY - 2012 DA - 2012// TI - Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours JO - Eur Radiol VL - 22 UR - https://doi.org/10.1007/s00330-011-2266-4 DO - 10.1007/s00330-011-2266-4 ID - Schreiter2012 ER - TY - JOUR AU - Beiderwellen, K. J. PY - 2013 DA - 2013// TI - Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results JO - Investig Radiol VL - 48 UR - https://doi.org/10.1097/RLI.0b013e3182871a7f DO - 10.1097/RLI.0b013e3182871a7f ID - Beiderwellen2013 ER - TY - JOUR AU - Gaertner, F. C. PY - 2013 DA - 2013// TI - Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors JO - Investig Radiol VL - 48 UR - https://doi.org/10.1097/RLI.0b013e31828234d0 DO - 10.1097/RLI.0b013e31828234d0 ID - Gaertner2013 ER - TY - JOUR AU - Hope, T. A. PY - 2015 DA - 2015// TI - Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor JO - Abdom Imaging VL - 40 UR - https://doi.org/10.1007/s00261-015-0409-9 DO - 10.1007/s00261-015-0409-9 ID - Hope2015 ER - TY - BOOK AU - Fleiss, J. L. AU - Levin, B. AU - Paik, M. C. PY - 2003 DA - 2003// TI - Statistical methods for rates and proportions PB - Wiley CY - Hoboken UR - https://doi.org/10.1002/0471445428 DO - 10.1002/0471445428 ID - Fleiss2003 ER - TY - JOUR AU - Yu, M. H. AU - Lee, J. M. AU - Hur, B. Y. PY - 2015 DA - 2015// TI - Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy JO - Eur Radiol VL - 25 UR - https://doi.org/10.1007/s00330-015-3615-5 DO - 10.1007/s00330-015-3615-5 ID - Yu2015 ER - TY - JOUR AU - Grazioli, L. AU - Ambrosini, R. AU - Frittoli, B. PY - 2017 DA - 2017// TI - Primary benign liver lesions JO - Eur J Radiol VL - 95 UR - https://doi.org/10.1016/j.ejrad.2017.08.028 DO - 10.1016/j.ejrad.2017.08.028 ID - Grazioli2017 ER - TY - JOUR AU - Ronot, M. AU - Clift, A. K. AU - Baum, R. P. AU - Singh, A. AU - Kulkarni, H. R. AU - Frilling, A. AU - Vilgrain, V. PY - 2018 DA - 2018// TI - Morphological and functional imaging for detecting and assessing the resectability of neuroendocrine liver metastases JO - Neuroendocrinology VL - 106 UR - https://doi.org/10.1159/000479293 DO - 10.1159/000479293 ID - Ronot2018 ER - TY - JOUR AU - Corrias, G. AU - Monti, S. AU - Horvat, N. PY - 2018 DA - 2018// TI - Imaging features of malignant abdominal neuroendocrine tumors with rare presentation JO - Clin Imaging VL - 51 UR - https://doi.org/10.1016/j.clinimag.2018.02.004 DO - 10.1016/j.clinimag.2018.02.004 ID - Corrias2018 ER - TY - JOUR AU - Kinahan, P. E. AU - Fletcher, J. W. PY - 2010 DA - 2010// TI - Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy JO - Semin Ultrasound CT MR VL - 31 UR - https://doi.org/10.1053/j.sult.2010.10.001 DO - 10.1053/j.sult.2010.10.001 ID - Kinahan2010 ER - TY - JOUR AU - Carideo, L. AU - Prosperi, D. AU - Panzuto, F. PY - 2019 DA - 2019// TI - Role of combined [68Ga]Ga-DOTA-SST analogues and [18F] FDG PET/CT in the management of GEP-NENs: a systematic review JO - J Clin Med VL - 8 UR - https://doi.org/10.3390/jcm8071032 DO - 10.3390/jcm8071032 ID - Carideo2019 ER - TY - JOUR AU - Tirosh, A. AU - Kebebew, E. PY - 2018 DA - 2018// TI - The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors JO - Future Oncol VL - 14 UR - https://doi.org/10.2217/fon-2017-0393 DO - 10.2217/fon-2017-0393 ID - Tirosh2018 ER - TY - JOUR AU - Beuthien-Baumann, B. PY - 2009 DA - 2009// TI - 18F-DOPA-PET in neuroendocrine tumours (NET) JO - Nuklearmediziner VL - 32 UR - https://doi.org/10.1055/s-0028-1112124 DO - 10.1055/s-0028-1112124 ID - Beuthien-Baumann2009 ER - TY - JOUR AU - Hoegerle, S. PY - 2001 DA - 2001// TI - Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors JO - Radiology VL - 220 UR - https://doi.org/10.1148/radiology.220.2.r01au25373 DO - 10.1148/radiology.220.2.r01au25373 ID - Hoegerle2001 ER - TY - JOUR AU - Armbruster, M. AU - Zech, C. J. AU - Sourbron, S. AU - Ceelen, F. AU - Auernhammer, C. J. AU - Rist, C. AU - Haug, A. AU - Singnurkar, A. AU - Reiser, M. F. AU - Sommer, W. H. PY - 2014 DA - 2014// TI - Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms JO - J Magn Reson Imaging VL - 40 UR - https://doi.org/10.1002/jmri.24363 DO - 10.1002/jmri.24363 ID - Armbruster2014 ER - TY - JOUR AU - Shenoy-Bhangle, A. AU - Baliyan, V. AU - Kordbacheh, H. AU - Guimaraes, A. R. AU - Kambadakone, A. PY - 2017 DA - 2017// TI - Diffusion weighted magnetic resonance imaging of liver: principles, clinical applications and recent updates JO - World J Hepatol VL - 9 UR - https://doi.org/10.4254/wjh.v9.i26.1081 DO - 10.4254/wjh.v9.i26.1081 ID - Shenoy-Bhangle2017 ER - TY - JOUR AU - Vilgrain, V. AU - Esvan, M. AU - Ronot, M. AU - Caumont-Prim, A. AU - Aubé, C. AU - Chatellier, G. PY - 2016 DA - 2016// TI - A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases JO - Eur Radiol VL - 26 UR - https://doi.org/10.1007/s00330-016-4250-5 DO - 10.1007/s00330-016-4250-5 ID - Vilgrain2016 ER - TY - JOUR AU - Belousova, E. AU - Karmazanovsky, G. AU - Kriger, A. PY - 2017 DA - 2017// TI - Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumor grades JO - Clin Radiol VL - 72 UR - https://doi.org/10.1016/j.crad.2016.10.021 DO - 10.1016/j.crad.2016.10.021 ID - Belousova2017 ER - TY - JOUR AU - Kaltenbach, B. AU - Wichmann, J. L. AU - Pfeifer, S. PY - 2018 DA - 2018// TI - Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT JO - Eur J Radiol VL - 105 UR - https://doi.org/10.1016/j.ejrad.2018.05.019 DO - 10.1016/j.ejrad.2018.05.019 ID - Kaltenbach2018 ER -